These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7003576)

  • 1. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
    Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
    Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
    [No Abstract]   [Full Text] [Related]  

  • 5. Labetalol and bendrofluazide: comparison of their antihypertensive effects.
    Horvath JS; Caterson RJ; Collett P; Duggin GG; Kelly DH; Tiller DJ
    Med J Aust; 1979 Jun; 1(13):626-8. PubMed ID: 386062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol in the treatment of hypertension in general practice.
    Forsell P; O'Sullivan J; Carson N
    Aust Fam Physician; 1979 Nov; 8(11):1165-6. PubMed ID: 393223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical trial in general practice. Part 1: Report and comments.
    Gill D; Ward A; Bridges-Webb C
    Aust Fam Physician; 1984 Jul; 13(7):522-3. PubMed ID: 6487172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different antihypertensive therapies on plasma lipids.
    Gomez G
    Practitioner; 1982 May; 226(1367):985-91. PubMed ID: 7100090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of labetolol and propranolol in patients with untreated hypertension].
    Wessel-Aas T; Walstad RA; Berg KJ
    Tidsskr Nor Laegeforen; 1981 Mar; 101(9-10):579-81. PubMed ID: 7221994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z; Bagatin J; Vidović A
    Lijec Vjesn; 1980 Nov; 102(11):619-23. PubMed ID: 7024692
    [No Abstract]   [Full Text] [Related]  

  • 20. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.